Human study to evaluate the effect of deer antlers on the growth of children

The 12 weeks, randomized, double-blinded, placebo-controlled human study to evaluate the effectiveness and safety of KGC deer antlers on the growth of children

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007386

Enrollment

100

Registered

2022-06-14

Start date

2022-03-14

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Deer antlers extracts 1,586 mg/20 mL, once a day, taking before a meal

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Boys and girls aged between 3 and 12 2) Children who have voluntarily agreed to participate in this study and have written informed consent signed by them or their representative

Exclusion criteria

Exclusion criteria: 1) Endocrine diseases (juvenile diabetes, hyperlipidemia, hypertension) 2) Diseases retarded growth (growth hormone deficiency due to pituitary disease) 3) Chromosomal abnormalities 4) Abnormal appearance 5) Not born with a normal range of weight (less than 2.6 kg or more than 4.4 kg) 6) Received hormone replacement therapy, calcitonin, phosphonate, growth hormone treatment within 6 months prior to screening test 7) Clinically significant acute or chronic disease of cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urological system, neuropsychiatric system, musculoskeletal system, inflammatory and hemato-oncological system, or gastrointestinal system 8) Taken medicines of health functional foods related to children's height growth within three months prior to screening test 9) Received antipsychotic medication within three months prior to screening test 10) Participated in another clinical trial within one month prior to screening test 11) Determined inappropriate due to other reasons such as clinical laboratory examination

Design outcomes

Primary

Measure	Time frame
height and weight	—

Secondary

Measure	Time frame
height and weight;height percentile;standard deviation score of height;standard deviation score of height for bone age;body mass index, waist circumference, hip circumference;bone age, predicted adult height estimated by bone age;IGF-1, IGFBP-3, IGF-1/IGFBP-3 ratio, estradiol	—

Countries

Korea, Republic of

Contacts

Public ContactSang-Min Kim

Kyung Hee University Oriental Medical Center

snowdayfood@naver.com+82-2-958-9168

Outcome results